Journal of Adolescent Health
Volume 40, Issue 2 , Pages 151-157 , February 2007

Extended Cycling of Combined Hormonal Contraceptives in Adolescents: Physician Views and Prescribing Practices

  • Kelly L. Gerschultz, B.S.

      Affiliations

    • University of Pittsburgh School of Medicine, Pittsburgh, Pennsylvania
    • ,
  • Gina S. Sucato, M.D., M.P.H.

      Affiliations

    • University of Pittsburgh School of Medicine, Pittsburgh, Pennsylvania
    • Division of Adolescent Medicine, Department of Pediatrics, University of Pittsburgh School of Medicine, Pittsburgh, Pennsylvania
    • Children’s Hospital of Pittsburgh, Pittsburgh, Pennsylvania
    • Corresponding Author InformationAddress correspondence to: Dr. Gina S. Sucato, Division of Adolescent Medicine, Children’s Hospital of Pittsburgh, 3705 Fifth Avenue, Pittsburgh, PA 15213.
    • ,
  • Teresa R. Hennon, M.D.

      Affiliations

    • Children’s Hospital of Pittsburgh, Pittsburgh, Pennsylvania
    • ,
  • Pamela J. Murray, M.D., M.H.P.

      Affiliations

    • University of Pittsburgh School of Medicine, Pittsburgh, Pennsylvania
    • Division of Adolescent Medicine, Department of Pediatrics, University of Pittsburgh School of Medicine, Pittsburgh, Pennsylvania
    • Children’s Hospital of Pittsburgh, Pittsburgh, Pennsylvania
    • Department of Obstetrics, Gynecology and Reproductive Sciences, Children’s Hospital of Pittsburgh, Pittsburgh, Pennsylvania
    • ,
  • Melanie A. Gold, D.O.

      Affiliations

    • University of Pittsburgh School of Medicine, Pittsburgh, Pennsylvania
    • Division of Adolescent Medicine, Department of Pediatrics, University of Pittsburgh School of Medicine, Pittsburgh, Pennsylvania
    • Children’s Hospital of Pittsburgh, Pittsburgh, Pennsylvania
    • Department of Obstetrics, Gynecology and Reproductive Sciences, Children’s Hospital of Pittsburgh, Pittsburgh, Pennsylvania

Received 7 June 2006 ,Accepted 13 September 2006.

References 

  1. Chandra A, Martinez GM, Mosher WD, et al. Fertility, family planning, and reproductive health of U.S. women: data from the 2002 National Survey of Family Growth. Vital Health Stat 23. 2005;25:1–160
  2. Sulak PJ, Carl J, Gopalakrishnan I, et al. Outcomes of extended oral contraceptive regimens with a shortened hormone-free interval to manage breakthrough bleeding. Contraception. 2004;70:281–287
  3. Kjerulff KH, Erickson BA, Langenberg PW. Chronic gynecological conditions reported by US women: findings from the National Health Interview Survey, 1984 to 1992. Am J Public Health. 1996;86:195–199
  4. Klein JR, Litt IF. Epidemiology of adolescent dysmenorrhea. Pediatrics. 1981;68:661–664
  5. Sulak PJ, Scow RD, Preece C, et al. Hormone withdrawal symptoms in oral contraceptive users. Obstet Gynecol. 2000;95:261–266
  6. Sulak PJ, Kuehl TJ, Ortiz M, Shull BL. Acceptance of altering the standard 21-day/7-day oral contraceptive regimen to delay menses and reduce hormone withdrawal symptoms. Am J Obstet Gynecol. 2002;186:1142–1149
  7. Association of Reproductive Health Professionals. Extended regimen oral contraceptives. Harris Poll. June 14–17, 2002. 2004. January 4, 2004 (Ref Type: Electronic Citation). http://www.arhp.org/healthcareproviders/cme/onlinecme/extendedregimencp/extendedregimenconsumer.cfm
  8. Association of Reproductive Health Professionals and National Association of Nurse Practitioners in Women’s Health. Annual meeting registrant survey. August–September, 2002. 2004. Accessed January 4, 2004. http://www.arhp.org/healthcareproviders/extendedOCsregistrantsurvey.cfm
  9. Wiegratz I, Hommel HH, Zimmermann T, Kuhl H. Attitude of German women and gynecologists towards long-cycle treatment with oral contraceptives. Contraception. 2004;69:37–42
  10. Sulak PJ, Buckley T, Kuehl TJ. Attitudes and prescribing preferences of health care professionals in the United States regarding use of extended-cycle oral contraceptives. Contraception. 2006;73:41–45
  11. Asch DA, Jedrziewski MK, Christakis NA. Response rates to mail surveys published in medical journals. J Clin Epidemiol. 1997;50:1129–1136
  12. Hulley SB, Cummings SR. Appendix 13E. In:  Hulley SB,  Cummings SR editor. Designing Clinical Research. 220:Baltimore, MD: Williams & Wilkins; 1988;
  13. den Tonkelaar I, Oddens BJ. Preferred frequency and characteristics of menstrual bleeding in relation to reproductive status, oral contraceptive use, and hormone replacement therapy use. Contraception. 1999;59:357–362
  14. Gold MA, Hatcher RA, Horwitz M, et al. Oral Contraceptives. In: Teen to Teen—Plain Talk from Teens about Sex, Self-Esteem, and Everything in Between. Dawsonville, GA: Bridging the Gap Communications; 2005;p. 104
  15. Sulak PJ, Cressman BE, Waldrop E, et al. Extending the duration of active oral contraceptive pills to manage hormone withdrawal symptoms. Obstet Gynecol. 1997;89:179–183
  16. Hamerlynck JV, Vollebregt JA, Doornebos CM, Muntendam P. Postponement of withdrawal bleeding in women using low-dose combined oral contraceptives. Contraception. 1987;35:199–205
  17. Shulman LP. The use of triphasic oral contraceptives in a continuous use regimen. Contraception. 2005;72:105–110
  18. Cachrimanidou AC, Hellberg D, Nilsson S, et al. Long-interval treatment regimen with a desogestrel-containing oral contraceptive. Contraception. 1993;48:205–216
  19. Laguardia KD, Stewart FH, Kaunitz AM, Westhoff CL. Comparison of bleeding/spotting profiles between an extended regimen and a cyclic regimen of transdermal norelgestromin/ethinyl estradiol during the first 56 days of treatment. Contraception. 2005;72:230
  20. American College of Obstetricians and Gynecologists. Gallup Survey Reveals Women Ob-Gyns Benefit from “Insider Knowledge”. Gallup Organization 2005 [cited 2005 May 15]. http://www.acog.org/from_home/publications/press_releases/nr12-09-03-2.cfm
  21. Machado RB, Fabrini P, Cruz AM, et al. Clinical and metabolic aspects of the continuous use of a contraceptive association of ethinyl estradiol (30 microg) and gestodene (75 microg). Contraception. 2004;70:365–370
  22. Wiegratz I, Kuhl H. Long-cycle treatment with oral contraceptives. Drugs. 2004;64:2447–2462
  23. Rey-Stocker I, Zufferey MM, Lemarchand MT, Rais M. The sensibility of the hypophysis, the gonads and the thyroid of adolescents before and after the administration of oral contraceptives (A resume). Pediatr Ann. 1981;10:15–20
  24. Schlaff WD, Lynch AM, Hughes HD, et al. Manipulation of the pill-free interval in oral contraceptive pill users: the effect on follicular suppression. Am J Obstet Gynecol. 2004;190:943–951
  25. Spona J, Elstein M, Feichtinger W, et al. Shorter pill-free interval in combined oral contraceptives decreases follicular development. Contraception. 1996;54:71–77
  26. Stewart FH, Kaunitz AM, Laguardia KD, et al. Extended use of transdermal norelgestromin/ethinyl estradiol: a randomized trial. Obstet Gynecol. 2005;105:1389–1396
  27. Miller L, Verhoeven CH, Hout J. Extended regimens of the contraceptive vaginal ring: a randomized trial. Obstet Gynecol. 2005;106:473–482
  28. Andrist LC, Arias RD, Nucatola D, et al. Women’s and providers’ attitudes toward menstrual suppression with extended use of oral contraceptives. Contraception. 2004;70:359–363

PII: S1054-139X(06)00350-8

doi: 10.1016/j.jadohealth.2006.09.013

Journal of Adolescent Health
Volume 40, Issue 2 , Pages 151-157 , February 2007

Article Tools

* Image Usage & Resolution